JP2010047606A - Constipation dissolving agent - Google Patents

Constipation dissolving agent Download PDF

Info

Publication number
JP2010047606A
JP2010047606A JP2009267775A JP2009267775A JP2010047606A JP 2010047606 A JP2010047606 A JP 2010047606A JP 2009267775 A JP2009267775 A JP 2009267775A JP 2009267775 A JP2009267775 A JP 2009267775A JP 2010047606 A JP2010047606 A JP 2010047606A
Authority
JP
Japan
Prior art keywords
starch
constipation
intestinal
foods
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009267775A
Other languages
Japanese (ja)
Inventor
Rei Shimotoyotome
玲 下豊留
Noriyuki Yajima
則幸 谷島
Naoki Yamamoto
尚基 山本
Takatoshi Murase
孝利 村瀬
Ichiro Tokimitsu
一郎 時光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2009267775A priority Critical patent/JP2010047606A/en
Publication of JP2010047606A publication Critical patent/JP2010047606A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide materials for foods, medicines, etc., which exert improving effects for constipation, intestinal environment, etc., are highly safe and widely applicable, and do not spoil the texture. <P>SOLUTION: A constipation dissolution agent, an agent for improving intestinal environment, an enhancer of intestinal mucus production, and an enhancer of production of intestinal short chain fatty acids have an effective component of hydroxypropylated starch. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、便秘の改善、腸内環境の改善及び腸管粘液の産生促進作用等を有し、食品又は医薬品として有用な素材に関する。   The present invention relates to a material useful as a food or a medicine, which has an effect of improving constipation, improving the intestinal environment, promoting the production of intestinal mucus, and the like.

近年、食習慣の変化や、ストレス、薬物、胃、腸、肝障害等によって、腸内のpHがアルカリ領域へ移行する傾向がある。このように腸内環境がアルカリ性に傾くと、ウエルシュ菌、大腸菌、腸球菌等の繁殖が活発化し、腸内腐敗、細菌による毒素や発癌性物質の産生等が起こるとされている。
また、食物繊維の摂取不足から、現代人の多くは便秘を経験することが多く、便秘を危険因子とする結腸癌、直腸癌もまた増加している。
従って、このような社会的背景から、便秘対策や腸内環境改善は極めて重要である。
In recent years, the pH in the intestine tends to shift to the alkaline region due to changes in eating habits, stress, drugs, stomach, intestines, liver disorders, and the like. In this way, when the intestinal environment is inclined to alkalinity, the growth of Clostridium perfringens, Escherichia coli, enterococci, etc. is activated, and intestinal rot, production of toxins and carcinogens by bacteria, etc. occur.
In addition, due to the lack of dietary fiber intake, many modern people often experience constipation, and colon cancer and rectal cancer, where constipation is a risk factor, are also increasing.
Therefore, from such a social background, measures against constipation and improvement of the intestinal environment are extremely important.

従来、便秘の改善や腸内環境の改善には、ビフィズス菌や乳酸菌等の有用菌を摂取したり、高食物繊維食の摂取が推奨されている。例えば、便秘の予防・改善に関連する食品素材としては、小麦ふすまに代表される水不溶性食物繊維、難消化性デキストリンに代表される水溶性食物繊維、高アミロースコーン澱粉等の消化抵抗性澱粉が挙げられ、糞便排泄量や回数、及び糞便の含水率を増大することにより軟便化する等の効果が知られている(例えば、非特許文献1〜4参照)。   Conventionally, in order to improve constipation and intestinal environment, intake of useful bacteria such as bifidobacteria and lactic acid bacteria and intake of a high dietary fiber diet have been recommended. For example, food materials related to the prevention and improvement of constipation include water-insoluble dietary fiber typified by wheat bran, water-soluble dietary fiber typified by indigestible dextrin, and digestion resistant starches such as high amylose corn starch. There are known effects such as softening by increasing the amount and frequency of fecal excretion and the water content of feces (see, for example, Non-Patent Documents 1 to 4).

しかしながら、従来の水不溶性食物繊維、水溶性食物繊維、消化抵抗性澱粉等の食品素材が上記の生理作用を発現するには、高用量かつ長期間摂取し続けなければならない。更にそれらを用いて飲食品を製造した場合、飲食品本来の持つ外観、味、歯触り、滑らかさ等の食感を損う場合が多いため、食品中に十分な量で含有させることが困難であり、適用分野が限定されたり、更にそのような飲食品を長期間摂取し続けるのが困難という問題があった。   However, in order for food materials such as conventional water-insoluble dietary fiber, water-soluble dietary fiber, and digestion-resistant starch to exhibit the above physiological effects, they must be ingested at a high dose for a long period of time. Furthermore, when foods and drinks are produced using them, it is often difficult to contain them in foods in sufficient amounts because they often impair the texture of foods and drinks, such as appearance, taste, texture, and smoothness. However, there are problems that application fields are limited, and that it is difficult to continue taking such foods and drinks for a long time.

ヒドロキシプロピル化された澱粉は、透明性が高くフィルム形成性に優れ、低温保存安定性、凍結・解凍安定性の高い性質を持つことが知られており、米国ではFDAで食品への使用が許可されている(例えば、非特許文献3参照)。
しかしながら、ヒドロキプロピル化された澱粉類に、便秘改善作用や腸内環境の改善作用があることはこれまでに知られていない。
Hydroxypropylated starch is known to have high transparency, excellent film-forming properties, low-temperature storage stability, and high freezing / thawing stability. US approved for use in food by FDA (For example, see Non-Patent Document 3).
However, it has not been known so far that hydroxypropylated starches have an effect of improving constipation or improving the intestinal environment.

Am J Gastroentero 1 1987 82(12):1259-63Am J Gastroentero 1 1987 82 (12): 1259-63 健康・栄養食品研究 1999 Vol.2 No.1 p44Health and Nutrition Food Research 1999 Vol.2 No.1 p44 Am J Clin Nutr 1995 62(1):121-30Am J Clin Nutr 1995 62 (1): 121-30 日本家政学会誌 1998 49(9): 985-992Journal of Japanese Society for Home Economics 1998 49 (9): 985-992

本発明は、便秘や腸内環境等を改善する効果を発揮し、安全性が高いと共に適用範囲が広く、且つ食感を損なうことが少ない食品、医薬品等の素材を提供することに関する。   The present invention relates to providing materials such as foods and pharmaceuticals that exhibit the effect of improving constipation, intestinal environment, etc., have high safety, have a wide range of applications, and do not impair the texture.

本発明者らは、従来の難消化性澱粉やセルロース、難消化性デキストリンに代表される食物繊維とは異なる物性を有し、便秘や腸内環境改善に有効な素材を探索した結果、ヒドロキシプロピル化された澱粉が、僅かな摂取量で、糞便の量やその含水率を増加させ、腸管内の短鎖脂肪酸を増加させて腸内pHを低下させると共に、腸管内のムチンの発現量を増加させる作用を有し、便秘や腸内環境の改善等に効果を発揮する食品、医薬品素材として有用であることを見出した。   As a result of searching for a material having physical properties different from those of dietary fibers represented by conventional resistant starch, cellulose and resistant dextrin and effective for improving constipation and intestinal environment, the present inventors have found that hydroxypropyl. The modified starch increases the amount of stool and its moisture content with a small intake, increases the short-chain fatty acids in the intestine and lowers the intestinal pH, and increases the expression of mucin in the intestine It has been found that it is useful as a food and pharmaceutical material that has the effect of causing constipation and improving the intestinal environment.

すなわち、本発明は、ヒドロキシプロピル化された澱粉を有効成分とする便秘改善剤、腸内環境改善剤、腸管粘液産生促進剤及び腸内短鎖脂肪酸産生促進剤を提供するものである。   That is, the present invention provides a constipation improving agent, an intestinal environment improving agent, an intestinal mucus production promoting agent and an intestinal short chain fatty acid production promoting agent comprising hydroxypropylated starch as an active ingredient.

本発明の便秘改善剤等は、便秘の改善、腸内短鎖脂肪酸の産生促進、腸内pH等の腸内環境の改善及び腸管粘液産生促進効果を発揮し、食品、医薬品等として有用である。特に、有効成分であるヒドロキシプロピル化澱粉又はその誘導体は、澱粉を原料とすることから人体に対する安全性に優れ、また糊化しやすいので、飲食品への適用範囲が広く、パン、麺類、焼き菓子(ケーキ、クッキー等)、ゼリー類、飲料等に配合した場合、それらが本来持つ食感を損なうことが少ない。また耐凍結性に優れ、解凍しても変質しにくいことから、各種飲食品として使用する場合にその有用性が高い。   The constipation-improving agent of the present invention is useful as a food, a pharmaceutical, etc., exhibiting constipation improvement, intestinal short-chain fatty acid production promotion, intestinal environment improvement such as intestinal pH and intestinal mucus production promotion effect . In particular, hydroxypropylated starch or a derivative thereof, which is an active ingredient, is excellent in safety to the human body because it uses starch as a raw material, and is easy to gelatinize, so it has a wide range of application to foods and drinks, bread, noodles, baked goods (Cakes, cookies, etc.), jellies, beverages, etc., are less likely to impair their original texture. Moreover, since it is excellent in freezing resistance and hardly changes in quality even after thawing, it is highly useful when used as various foods and drinks.

本発明のヒドロキシプロピル化された澱粉は、澱粉又は加工澱粉を通常の方法によりヒドロキシプロピル化することにより得ることができる。具体的にはプロピレンオキサイドを澱粉に反応させることにより得ることができる。
また、ナショナルフリジェックス(タピオカ由来、ナショナルスターチアンドケミカル社)、ナショナル1658(コーン由来、ナショナルスターチアンドケミカル社)、サームフロー(ワキシーコーン由来、ナショナルスターチアンドケミカル社)、サームテックス(ワキシーコーン由来、ナショナルスターチアンドケミカル社)等の市販品を用いることもできる。
The hydroxypropylated starch of the present invention can be obtained by hydroxypropylating starch or modified starch by a conventional method. Specifically, it can be obtained by reacting propylene oxide with starch.
National Frigex (from Tapioca, National Starch and Chemical), National 1658 (from Corn, National Starch and Chemical), Thermal Flow (from Waxy Corn, National Starch and Chemical), Thermtex (from Waxy Corn, National Commercial products such as Starch and Chemical Co.) can also be used.

原料澱粉としては、例えばワキシーコーン澱粉、コーン澱粉、小麦澱粉、米澱粉、糯米澱粉、馬鈴薯澱粉、甘露澱粉、タピオカ澱粉、サゴ澱粉等が挙げられるが、アミロペクチン含量が70重量%以上、好ましくは75〜100%、更に好ましくは90〜100%であるものが、糊液の透明性が高く、飲食品に応用した場合にその外観を損わず、適用範囲が広くなることより好ましい。中でも、原料澱粉としては、ワキシーコーン澱粉、タピオカ澱粉が好ましい。   Examples of the raw material starch include waxy corn starch, corn starch, wheat starch, rice starch, glutinous rice starch, potato starch, sweet potato starch, tapioca starch, sago starch and the like. It is more preferable that the content is -100%, more preferably 90-100%, because the paste liquid has high transparency, and when applied to foods and drinks, its appearance is not impaired and the application range is widened. Among these, waxy corn starch and tapioca starch are preferable as the raw material starch.

本発明における「ヒドロキシプロピル化された澱粉」には、他の加工処理を組み合わせることにより得られるヒドロキシプロピル化された澱粉も含まれる。組み合わせることのできる加工処理としては酢酸、オクテニルコハク酸、リン酸等のエステル化処理やヒドロキシプロピル化以外のカルボキシメチルエーテル化等によるエーテル化処理、トリメタリン酸塩、ヘキサメタリン酸塩、オキシ塩化リン、アジピン酸、エピクロルヒドリン等、常用の架橋剤を用いた架橋化処理、酸化処理、酸処理、漂白処理、湿熱処理、熱処理、酵素処理等が挙げられ、その内1種又は2種以上の加工を組み合わせても良い。中でも、エステル化処理が好ましく、リン酸化処理、特にリン酸架橋処理が好ましい。リン酸化処理の程度としては、結合リン含量が0.0001〜2%の範囲が挙げられるが、好ましくは0.0001〜0.5%、更に好ましくは0.0001〜0.2%であるものが食感等の面から好ましい。   The “hydroxypropylated starch” in the present invention includes a hydroxypropylated starch obtained by combining other processing treatments. Processing that can be combined includes esterification of acetic acid, octenyl succinic acid, phosphoric acid, etc., etherification by carboxymethyl etherification other than hydroxypropylation, trimetaphosphate, hexametaphosphate, phosphorus oxychloride, adipic acid , Epichlorohydrin and the like, crosslinking treatment using a conventional crosslinking agent, oxidation treatment, acid treatment, bleaching treatment, wet heat treatment, heat treatment, enzyme treatment, etc. may be mentioned, of which one or more of them may be combined good. Of these, esterification treatment is preferred, and phosphorylation treatment, particularly phosphoric acid crosslinking treatment is preferred. As the degree of phosphorylation treatment, the bound phosphorus content is in the range of 0.0001 to 2%, preferably 0.0001 to 0.5%, more preferably 0.0001 to 0.2%. Is preferable from the viewpoint of texture and the like.

ヒドロキシプロピル化の程度としては、置換度(澱粉中の無水グルコース1残基当たりのヒドロキシプロピル基の数)が0.001〜1であるのが好ましく、より好ましくは0.05〜0.5であり、更に0.1〜0.3であるのが好ましい。   As the degree of hydroxypropylation, the degree of substitution (number of hydroxypropyl groups per anhydroglucose residue in starch) is preferably 0.001 to 1, more preferably 0.05 to 0.5. Yes, and preferably 0.1 to 0.3.

上記ヒドロキシプロピル化された澱粉は、澱粉から簡単な工程で、高純度で比較的安価に製造できる。また安全性が高く、従来の食物繊維や難消化性澱粉と比較して、各種飲食品、医薬品、ペットフード等に用いたときの違和感がない。また、耐冷凍性に優れているので、解凍による変質が起こりにくいという利点を有し得る。   The hydroxypropylated starch can be produced from starch with high purity and relatively low cost by a simple process. Moreover, it is highly safe and has no sense of incongruity when used in various foods, medicines, pet foods, etc., as compared with conventional dietary fiber and resistant starch. Moreover, since it is excellent in refrigeration resistance, it can have the advantage that alteration by thaw is unlikely to occur.

そして、ヒドロキシプロピル化された澱粉は、後記実施例に示すように、第1に、糞便の量やその含水率を増加させ、軟便化させる作用を有することから、便秘を危険因子とする結腸癌や直腸癌の予防等の効果を発揮する。第2に、腸管内の短鎖脂肪酸を増加させ、腸内pHを低下させる作用を有することから、腸内環境の悪化に起因する結腸癌や直腸癌を予防したり、カルシウム吸収を促進する等の効果を発揮する。第3に腸管内のムチンの発現量を増加させる作用を有することから、粘液により腸管粘膜が保護され、大腸炎及び結腸癌や直腸癌の予防等の効果を発揮し得る。
従って、本発明のヒドロキシプロピル化された澱粉は、便秘改善剤、腸内環境改善剤、腸管粘液産生促進剤、腸内短鎖脂肪酸産生促進剤(以下、便秘改善剤等という)として、ヒト若しくは動物用の食品又は医薬品の素材となり得る。
And since the hydroxypropylated starch has the action of increasing the amount of stool and its water content and softening the stool, as shown in the examples below, colon cancer with constipation as a risk factor It exerts effects such as prevention of rectal cancer. Secondly, it has the effect of increasing the short-chain fatty acids in the intestinal tract and lowering the intestinal pH, thus preventing colon cancer and rectal cancer resulting from deterioration of the intestinal environment, promoting calcium absorption, etc. Demonstrate the effect. Thirdly, since it has the action of increasing the expression level of mucin in the intestine, the mucous membrane protects the intestinal mucosa and can exert effects such as prevention of colitis, colon cancer and rectal cancer.
Therefore, the hydroxypropylated starch of the present invention is used as a constipation improving agent, intestinal environment improving agent, intestinal mucus production promoter, intestinal short chain fatty acid production promoter (hereinafter referred to as constipation improving agent, etc.) It can be a material for animal food or medicine.

本発明の便秘改善剤等は、ヒドロキシプロピル化澱粉の一種以上を単体でヒト及び動物に投与できる他、各種飲食品、医薬品、ペットフード等に配合して摂取することができる。食品としては、便秘の改善、腸内環境改善、Ca吸収促進、消化管粘膜保護等の生理機能をコンセプトとする美容食品、病者用食品、特定保健用食品に応用できる。医薬品として使用する場合は、例えば、錠剤、顆粒剤等の経口用固形製剤や、内服液剤、シロップ剤等の経口用液体製剤とすることができる。
尚、経口用固形製剤を調製する場合には、本発明のヒドロキシプロピル化澱粉に賦形剤、必要に応じて結合剤、崩壊剤、滑沢剤、着色剤、矯味剤、矯臭剤等を加えた後、常法により錠剤、被覆錠剤、顆粒剤、散剤、カプセル剤等を製造することができる。また、経口用液体製剤を調製する場合は、矯味剤、緩衝剤、安定化剤、矯味剤等を加えて常法により内服液剤、シロップ剤、エリキシル剤等を製造することができる。
The constipation-improving agent and the like of the present invention can be ingested by mixing one or more hydroxypropylated starches alone and in humans and animals, and in various foods, medicines, pet foods and the like. As food, it can be applied to beauty foods, illness foods and foods for specified health use based on physiological functions such as improvement of constipation, improvement of intestinal environment, promotion of Ca absorption, and protection of gastrointestinal mucosa. When used as a pharmaceutical, for example, oral solid preparations such as tablets and granules, and oral liquid preparations such as oral liquids and syrups can be used.
When preparing an oral solid preparation, an excipient, if necessary, a binder, a disintegrant, a lubricant, a coloring agent, a corrigent, a corrigent and the like are added to the hydroxypropylated starch of the present invention. Thereafter, tablets, coated tablets, granules, powders, capsules and the like can be produced by conventional methods. Moreover, when preparing a liquid preparation for oral use, a liquid preparation, a syrup, an elixir, etc. can be manufactured by a conventional method by adding a corrigent, a buffer, a stabilizer, a corrigent and the like.

上記各製剤中に配合されるべきヒドロキシプロピル化された澱粉の配合量は、通常5〜100重量%、好ましくは20〜100重量%、更に好ましくは30〜100重量%とするのが好ましい。   The blending amount of the hydroxypropylated starch to be blended in each of the above preparations is usually 5 to 100% by weight, preferably 20 to 100% by weight, and more preferably 30 to 100% by weight.

本発明の便秘改善剤等の投与量(有効摂取量)は、一日当り0.01g/kg体重以上とするのが好ましく、特に0.1g/kg体重以上、更に0.4g/kg体重以上とするのが好ましい。   The dose (effective intake) of the constipation improving agent of the present invention is preferably 0.01 g / kg body weight or more per day, particularly 0.1 g / kg body weight or more, more preferably 0.4 g / kg body weight or more. It is preferable to do this.

試験例1 便秘改善作用・腸内環境改善作用・腸管粘液産生促進作用
コーン澱粉は、ナショナルスターチアンドケミカル社から入手した。ヒドロキシプロピル化された澱粉として、一般に市販されているナショナル1658(コーン由来、ナショナルスターチアンドケミカル社)、サームフロー(ワキシーコーン由来、ナショナルスターチアンドケミカル社)、及び上記コーン澱粉をJ Nutr 1998 128(5):848-54に記載の方法でヒドロキシプロピル化したものを用いた。
Test Example 1 Constipation improving action, intestinal environment improving action, intestinal mucus production promoting action Corn starch was obtained from National Starch and Chemical Company. As hydroxypropylated starch, commercially available National 1658 (corn-derived, National Starch and Chemical Company), Thermoflow (waxy corn-derived, National Starch and Chemical Company), and the above-mentioned corn starch were converted into J Nutr 1998 128 (5 ): Hydroxypropylated by the method described in 848-54.

SDラット(雄、8週令)を1群5匹とし、各種澱粉を用いて、表1に示す配合で調製した食餌を用いて1週間飼育した。この間毎日、糞便の乾燥重量と含水率を測定した。飼育後、ラットを屠殺し、盲腸内容物のpH、及び短鎖脂肪酸量(酢酸、プロピオン酸、酪酸の総量)を測定した。更にラット結腸を摘出し、ノーザンブロット法により、ムチン遺伝子(MUC3)の発現を定量した。
尚、pHは盲腸内容物を蒸留水で2倍希釈後、pHメーターにて測定し、短鎖脂肪酸は盲腸内容物を0.05N H2SO4で10倍希釈後、HPLC(溶離液:0.12N硫酸カラム:IC sep TCE-10N 300(トンラスジェノジック社)、流速0.4mL/分で定量した。
ラットの糞便排泄量、平均糞便含水率、盲腸内pH、盲腸内短鎖脂肪酸量、ムチン発現量(コーン澱粉を100とした場合の相対量)を表2に示す。
SD rats (male, 8 weeks old) were grouped into 5 animals per group, and were bred for 1 week using diets prepared with the composition shown in Table 1 using various starches. During this time, the dry weight and moisture content of feces were measured every day. After breeding, the rats were sacrificed, and the pH of the cecum contents and the amount of short-chain fatty acids (total amount of acetic acid, propionic acid and butyric acid) were measured. Further, the rat colon was excised, and the mucin gene (MUC3) expression was quantified by Northern blotting.
The pH was measured with a pH meter after diluting the cecal contents with distilled water, and the short chain fatty acid was diluted with 0.05N H2SO4 ten times with HPLC (eluent: 0.12N sulfuric acid). Column: IC sep TCE-10N 300 (Tongras Genocic), quantified at a flow rate of 0.4 mL / min.
Table 2 shows the fecal excretion, average fecal water content, cecal pH, cecal short-chain fatty acid content, and mucin expression (relative amount when corn starch is 100).

Figure 2010047606
Figure 2010047606

Figure 2010047606
Figure 2010047606

表2の結果から、ヒドロキシプロピル化された澱粉(コーン、ワキシーコーン由来)を5%配合した飼料を摂取したラットでは、原料澱粉(コーン澱粉)を配合した飼料を摂取したマウスに比較して、糞便量が多く、糞便含水率が高く、便秘改善効果が認められることがわかる。また盲腸内短鎖脂肪酸濃度が高いことから、盲腸内pHが低くなっており、腸内環境改善効果が認められることがわかる。更にムチン(MUC3)発現量も多く、腸管粘液産生促進効果が認められることがわかる。   From the results of Table 2, in rats fed with a diet containing 5% of hydroxypropylated starch (derived from corn and waxy corn), compared to mice fed with a diet formulated with raw starch (corn starch), It can be seen that the amount of feces is large, the water content of feces is high, and the effect of improving constipation is observed. Moreover, since the concentration of short-chain fatty acids in the cecum is high, it can be seen that the pH in the cecum is low and an effect of improving the intestinal environment is observed. Furthermore, the expression level of mucin (MUC3) is also large, indicating that an intestinal mucus production promoting effect is observed.

Claims (4)

腸管粘液産生促進のためのヒドロキシプロピル化された澱粉の使用(但し、ヒトの医薬としての使用を除く)。   Use of hydroxypropylated starch to promote intestinal mucus production (except for use as a human medicine). 大腸炎、結腸癌及び/又は直腸癌の予防のためのヒドロキシプロピル化された澱粉の使用(但し、ヒトの医薬としての使用を除く)。   Use of hydroxypropylated starch for the prevention of colitis, colon cancer and / or rectal cancer (except for use as a human medicine). 腸管粘液産生促進作用を有するものであることを特徴とする食品の有効成分としてのヒドロキシプロピル化された澱粉の使用。   Use of a hydroxypropylated starch as an active ingredient of a food, characterized by having an intestinal mucus production promoting action. 大腸炎、結腸癌及び/又は直腸癌の予防作用を有するものであることを特徴とする食品の有効成分としてのヒドロキシプロピル化された澱粉の使用。   Use of hydroxypropylated starch as an active ingredient in foods characterized by having preventive action against colitis, colon cancer and / or rectal cancer.
JP2009267775A 2009-11-25 2009-11-25 Constipation dissolving agent Pending JP2010047606A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009267775A JP2010047606A (en) 2009-11-25 2009-11-25 Constipation dissolving agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009267775A JP2010047606A (en) 2009-11-25 2009-11-25 Constipation dissolving agent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003109959A Division JP4463494B2 (en) 2003-04-15 2003-04-15 Constipation improving agent

Publications (1)

Publication Number Publication Date
JP2010047606A true JP2010047606A (en) 2010-03-04

Family

ID=42064971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009267775A Pending JP2010047606A (en) 2009-11-25 2009-11-25 Constipation dissolving agent

Country Status (1)

Country Link
JP (1) JP2010047606A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0479861A (en) * 1990-07-20 1992-03-13 Matsutani Kagaku Kogyo Kk Preparation of fish paste food containing dietary fiber
JPH0567A (en) * 1991-06-20 1993-01-08 Towa Kasei Kogyo Kk Calcium-and dietary-fiber containing food and drink and production thereof
JPH06277011A (en) * 1993-03-29 1994-10-04 Kyowa Hakko Kogyo Co Ltd Premix
JPH10243777A (en) * 1997-03-04 1998-09-14 Matsutani Chem Ind Ltd Composition for reinforcing dietary fiber and dietary fiber-reinforced food using the same
JP2001055338A (en) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd Pharmacological composition comprising yeast cell wall fraction
JP2001503016A (en) * 1996-03-20 2001-03-06 ザ、ユニバーシティ、オブ、ニュー、サウス、ウェイルズ Changes in microbial population in the digestive tract

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0479861A (en) * 1990-07-20 1992-03-13 Matsutani Kagaku Kogyo Kk Preparation of fish paste food containing dietary fiber
JPH0567A (en) * 1991-06-20 1993-01-08 Towa Kasei Kogyo Kk Calcium-and dietary-fiber containing food and drink and production thereof
JPH06277011A (en) * 1993-03-29 1994-10-04 Kyowa Hakko Kogyo Co Ltd Premix
JP2001503016A (en) * 1996-03-20 2001-03-06 ザ、ユニバーシティ、オブ、ニュー、サウス、ウェイルズ Changes in microbial population in the digestive tract
JPH10243777A (en) * 1997-03-04 1998-09-14 Matsutani Chem Ind Ltd Composition for reinforcing dietary fiber and dietary fiber-reinforced food using the same
JP2001055338A (en) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd Pharmacological composition comprising yeast cell wall fraction

Similar Documents

Publication Publication Date Title
JP5026657B2 (en) Obesity prevention / amelioration agent
JP2020203903A (en) Fiber-rich maltooligosaccharides having low glucose bioavailability, and use thereof in human food and animal feed
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) et al. Re‐evaluation of oxidised starch (E 1404), monostarch phosphate (E 1410), distarch phosphate (E 1412), phosphated distarch phosphate (E 1413), acetylated distarch phosphate (E 1414), acetylated starch (E 1420), acetylated distarch adipate (E 1422), hydroxypropyl starch (E 1440), hydroxypropyl distarch phosphate (E 1442), starch sodium octenyl succinate (E 1450), acetylated oxidised starch (E 1451) and starch aluminium octenyl succinate (E 1452) as food additives
JP2006342085A (en) Gip secretion inhibitor
EP2004138B1 (en) Gastric raft composition comprising processed starches for inducing satiety
AU2005280992B2 (en) Preventive/remedy for obesity
JP2006508916A (en) Branched alpha-glucan for weight management
JP4463494B2 (en) Constipation improving agent
JP5581129B2 (en) Obesity prevention / amelioration agent
AU2005280994B2 (en) Agent for preventing and ameliorating obesity
JP2010047606A (en) Constipation dissolving agent
JP2017221130A (en) Food and drink composition
JP5248776B2 (en) Composition and use thereof
JP2021184704A (en) Grain-like granular food
JP2922504B1 (en) Thickening composition for assisting swallowing and taking of water, food and medicine
JP2010053138A (en) Obesity-preventing/improving agent
JP2017095403A (en) Triglyceride-lowering drugs, body weight-suppressing drugs, excretion-increasing drugs, foods and drinks, feed and medicines
JP5490350B2 (en) Endurance improver
JP2011236239A (en) Gip secretion inhibitor
JP2011037715A (en) Body weight variation inhibitor

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100629

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101026